Opening book details…
About this Medicine article
P617: FIXED-DURATION (FD) IBRUTINIB + VENETOCLAX FOR FIRST-LINE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)/SMALL LYMPHOCYTIC LYMPHOMA (SLL): 4-Y FOLLOW-UP FROM FD COHORT OF PHASE 2 CAPTIVATE STUDY by Ghia, Paolo (author);Allan, John (author);Siddiqi, Tanya (author);Wierda, William G. (author);Tam, Constantine (author);Moreno, Carol (author);Tedeschi, Alessandra (author);Szafer-Glusman, Edith (author);Zhou, Cathy (author);Abbazio, Chris (author);Dean, Jim (author);Szoke, Anita (author);Barr, Paul M. (author) is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Ghia, Paolo (author);Allan, John (author);Siddiqi, Tanya (author);Wierda, William G. (author);Tam, Constantine (author);Moreno, Carol (author);Tedeschi, Alessandra (author);Szafer-Glusman, Edith (author);Zhou, Cathy (author);Abbazio, Chris (author);Dean, Jim (author);Szoke, Anita (author);Barr, Paul M. (author)
- Publisher
- Ovid Technologies (Wolters Kluwer Health)
- Published
- 2023
- Language
- EN
- Field
- Medicine (Health Sciences)